Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Panamycin 607 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

100905-89-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 4,13,19,20-Tetraoxatricyclo[14.2.1.17,10]eicosane-3,12-dione,5-[(1R)-1-[(2R,5S)-5-[(2R)-2-(dimethylamino)pentyl]tetrahydro-2-furanyl]ethyl]-2,6,11-trimethyl-14-propyl-,(1R,2S,5S,6R,7S,10R,11R,14S,16S)

    Cas No: 100905-89-3

  • No Data

  • No Data

  • 5

  • Hangzhou J&H Chemical Co., Ltd.
  • Contact Supplier
  • 100905-89-3 Structure
  • Basic information

    1. Product Name: Panamycin 607
    2. Synonyms: Panamycin 607
    3. CAS NO:100905-89-3
    4. Molecular Formula: C35H61NO7
    5. Molecular Weight: 607.86134
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 100905-89-3.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 713.3°Cat760mmHg
    3. Flash Point: 385.2°C
    4. Appearance: /
    5. Density: 1.006g/cm3
    6. Vapor Pressure: 3.4E-20mmHg at 25°C
    7. Refractive Index: 1.468
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: Panamycin 607(CAS DataBase Reference)
    11. NIST Chemistry Reference: Panamycin 607(100905-89-3)
    12. EPA Substance Registry System: Panamycin 607(100905-89-3)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 100905-89-3(Hazardous Substances Data)

100905-89-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 100905-89-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,9,0 and 5 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 100905-89:
(8*1)+(7*0)+(6*0)+(5*9)+(4*0)+(3*5)+(2*8)+(1*9)=93
93 % 10 = 3
So 100905-89-3 is a valid CAS Registry Number.
InChI:InChI=1/C35H61NO7/c1-9-11-25(36(7)8)19-27-13-15-29(39-27)21(3)33-22(4)30-17-18-32(42-30)24(6)34(37)41-26(12-10-2)20-28-14-16-31(40-28)23(5)35(38)43-33/h21-33H,9-20H2,1-8H3/t21-,22+,23+,24-,25?,26+,27+,28+,29-,30+,31-,32-,33+/m1/s1

100905-89-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name Panamycin 607

1.2 Other means of identification

Product number -
Other names Panamycin-607

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:100905-89-3 SDS

100905-89-3Upstream product

100905-89-3Relevant articles and documents

A convergent strategy for the pamamycin macrodiolides: Total synthesis of pamamycin-607, pamamycin-593, and pamamycin-621D precursors

Lanners, Steve,Norouzi-Arasi, Hassan,Salom-Roig, Xavier J.,Hanquet, Gilles

, p. 7086 - 7089 (2007)

A convergent total synthesis of pamamycin-607 (1), isolated from Streptomyces alboniger, was achieved by an E-Z isomerization of a tetrahydrofuran alkylidene and a regio- and diastereoselective solvent-dependent cyclo-C6H11BCl/Etsub

Total syntheses of pamamycin 607 and methyl nonactate: Stereoselective cyclisation of homoallylic alcohols that had been prepared with remote stereocontrol using allylstannanes

Germay, Olivier,Kumar, Naresh,Moore, Christopher G.,Thomas, Eric J.

, p. 9709 - 9733 (2013/01/16)

The tin(iv) chloride mediated cyclisation of (Z)-homoallylic alcohols using phenylselenenyl chloride or phthalimide in the presence of a Lewis acid followed by reductive removal of the phenylselenenyl group was found to give 2,5-cis-disubstituted tetrahydrofurans with excellent stereocontrol. Using this procedure, (2S,4S,8R,6Z)-9-benzyloxy-2-tert-butyldiphenylsilyloxy-8-methylnon-6- en-4-ol (11), prepared stereoselectively via the tin(iv) chloride promoted reaction between the (R)-5-benzyloxy-4-methylpent-2-enyl(tributyl)stannane (3) and (S)-3-tert-butyldiphenylsilyloxybutanal (10), gave (2S,3R,6S,8S)-1- benzyloxy-8-tert-butyldiphenylsilyloxy-3,6-epoxy-2-methylnonane (13) after deselenation. This tetrahydrofuran was selectively deprotected, oxidized and esterified to give methyl nonactate (2). Having established this synthesis of 2,5-cis-disubstituted tetrahydrofurans, it was applied to complete a synthesis of pamamycin 607 (1). (2S,3R,6S,8R)-1-Benzyloxy-8-[N-methyl-N-(toluene-4- sulfonyl)amino]-3,6-epoxy-2-methylundecane (35) was prepared stereoselectively from (R)-3-[N-(toluene-4-sulfonyl)-N-methylamino]hexanal (32) by reaction with the stannane 3 followed by cyclisation of the resulting alkenol 33 and deselenation. Following debenzylation and oxidation, an aldol reaction of the aldehyde 37 using the lithium enolate of 2,6-dimethylphenyl propanoate (61) gave mainly the 2,3-anti-3,4-syn-adduct 48. After protection of the secondary alcohol as its tert-butyldimethylsilyl ether 49, reduction using DIBAL-H and oxidation, the resulting aldehyde, (2S,3S,4R,5R,8S,10R)-3-tert- butyldimethylsilyloxy-2,4-dimethyl-5,8-epoxy-10-[N-methyl-N-(toluene-4-sulfonyl) amino]tridecanal (62), was taken through to the bis-tetrahydrofuran 65 by repeating the sequence of the reactions with the stannane 3, cyclisation and deselenation. The N-(toluene-4-sulfonyl) group was then replaced by an N-(tert-butoxycarbonyl) group and O-debenzylation and oxidation gave the carboxylic acid 70 that corresponds to the C(1)-C(18) fragment of pamamycin 607 (1). Similar chemistry was used to prepare the C(1′)-C(11′) fragment 89 of the pamamycin, except that in this case the configuration of the secondary alcohol introduced by the allylstannane reaction had to be inverted using a Mitsunobu reaction before the cyclisation. Esterification of the carboxylic acid of the C(1)-C(18)-fragment 70 using the alcohol 89 of the C(1′)-C(11′) fragment followed by selective deprotection, macrocyclisation, N-deprotection and N-methylation gave pamamycin 607 (1) that was identical to a sample of the natural product. The Royal Society of Chemistry 2012.

Stereoselective synthesis of pamamycin-607

Jeong, Eun Jeong,Kang, Eun Joo,Sung, Lee Taek,Hong, Sung Kil,Lee, Eun

, p. 14655 - 14662 (2007/10/03)

A macrodiolide antibiotic pamamycin-607 was synthesized by joining two hydroxy acid components. Three cis-2, 5-disubstituted tetrahydrofuran rings in the molecule were stereoselectively prepared by radical cyclization reactions of β-alkoxyvinyl ketone intermediates and a β-alkoxymethacrylate substrate. The key step of the synthesis is characterized by the predominant threo product formation in the radical cyclization reaction of a β-alkoxymethacrylate intermediate.

Total synthesis of pamamycin-607

Wang, Yuzhou,Bernsmann, Heiko,Gruner, Margit,Metz, Peter

, p. 7801 - 7804 (2007/10/03)

The macrodiolide antibiotic pamamycin-607 has been synthesized by coupling of the two hydroxy acid constituents using the Yamaguchi method. While the final lactonization with formation of the ester linkage between C(1) and the C(8′) oxygen proceeded with complete C(2) epimerization, the alternative ring closure involving the carboxylic acid of the smaller fragment and the hydroxyl group of the larger fragment yielded the target molecule.

Total synthesis of pamamycin 607: Applications of remote asymmetric induction in organic synthesis

Germay, Olivier,Kumar, Naresh,Thomas, Eric J.

, p. 4969 - 4974 (2007/10/03)

A total synthesis of pamamycin 607 1 is described. The synthesis of the C(1)-C(18) fragment involved the tin(IV) chloride-promoted reaction between (3R)-3-(N-methyl)tosylaminohexanal 18 and the allylstannane 4 followed by cyclisation and reductive removal of the phenylselanyl group to give the tetrahydrofuran 20 which was taken through to the aldehyde 21. Aldol addition of the lithium enolate derived from 2,6-dimethylphenyl propanoate to this aldehyde followed by O-silylation gave the silyl ether 25 as the major product. This was converted into the aldehyde 31 which gave the bis-tetrahydrofuran 33 on reaction with the stannane 4, cyclisation and reduction. Exchange of the N-protecting group, hydrogenolysis and oxidation then gave the acid 34. This was esterified using the alcohol 42, which had been prepared from the aldehyde 35 and the stannane ent-4 using similar chemistry, to give the ester 43. Deprotection gave the seco-acid 44 and cyclisation, N-deprotection and N-methylation gave pamamycin 607 1.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 100905-89-3